BeStock  
Stocks › Biotechnology › REPL

Replimune REPL

US equityMarket cap rank #2747Biotechnology
$19.07 −$0.16 (-0.83%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $19.09 +0.10%
Open$18.84
Prev close$19.23
Day range$18.69 – $19.50
Volume1.96M
Market cap$1.81B
P/E (TTM)–
Dividend yield–

REPL Stock News

Headlines matching Replimune or the REPL ticker, most recent first.

  • Sri Trang Gloves: REPL-General Announcement-Reporting Share Repurchase form for Financial Management Purposes No.2 (Revised Date)SGX · 8 Sep 2026 · Direct mention
  • BMO Capital Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $20Market news · 11 Sep 2026 · Direct mention
  • Wedbush Upgrades Replimune(REPL.US) to Buy Rating, Raises Target Price to $19 PositiveMarket news · 7 Aug 2026 · Direct mention
  • Piper Sandler Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $14Market news · 7 Aug 2026 · Direct mention
  • BMO Capital Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $20 PositiveMarket news · 7 Aug 2026 · Direct mention
  • Leerink Partners Initiates Replimune(REPL.US) With Buy Rating, Announces Target Price $17Market news · 4 Aug 2026 · Direct mention
  • Frasers Property: REPL-General Announcement-Issue of S$150 Million Fixed Rate Notes Due 2036 By Frasers Property Treasury Pte. Ltd.SGX · 28 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $21 PositiveMarket news · 26 Aug 2026 · Direct mention
  • Jefferies Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $24 PositiveMarket news · 17 Aug 2026 · Direct mention
  • Wedbush Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $19Market news · 17 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $20 PositiveMarket news · 11 Aug 2026 · Direct mention
  • Cantor Fitzgerald Upgrades Replimune(REPL.US) to Buy Rating PositiveMarket news · 31 Jul 2026 · Direct mention
  • Wedbush Upgrades Replimune(REPL.US) to Buy Rating, Raises Target Price to $12 PositiveMarket news · 31 Jul 2026 · Direct mention
  • BMO Capital Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $16Market news · 31 Jul 2026 · Direct mention
  • Wedbush Downgrades Replimune(REPL.US) to Hold Rating, Cuts Target Price to $9 NegativeMarket news · 28 Jul 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on REPL.

Sign in to join the discussion.

Scroll to Top